EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
39 hedge funds and large institutions have $64.6M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
39
Holding in Top 10
–
Calls
$15K
Puts
–
Top Buyers
| 1 | +$9.76M | |
| 2 | +$2.96M | |
| 3 | +$2.27M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.39M |
| 5 |
CIM
Cowen Investment Management
New York
|
+$729K |
Top Sellers
| 1 | -$3.22M | |
| 2 | -$833K | |
| 3 | -$663K | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$313K |
| 5 |
BlackRock
New York
|
-$243K |